Molecular Templates
Austin, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
EE
Eric E. PomaFounder
JS
Jason S. KimNamed on SEC filing
DR
David R. HoffmannNamed on SEC filing
DH
David HirschNamed on SEC filing
DV
David ValacerNamed on SEC filing
HS
Harold SelickNamed on SEC filing
Board
MB
Michael BroxsonBoard director
SM
Scott MorensteinBoard director
KM
Kevin M. LalandeBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$95M disclosed across 4 rounds · 2017–2023
▶$20MraisedJul 2023 · 19 investors · BiotechnologyRule 506(b)
▶$20MraisedJul 2023 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jason KimExecutive Officer
- Eric E. PomaExecutive Officer, Director
- David HoffmannDirector
- Roger J. WaltzmanExecutive Officer
- Jonathan LanfearDirector
- Kevin LalandeDirector
- Corsee SandersDirector
- Harold SelickDirector
- Gabriela GruiaDirector
- Offering amount
- $90.7M
- Amount sold
- $20M
- Sales commissions
- $2.7M
- Placement agents
- Stifel, Nicolaus & Company, Incorporated
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedDec 2019 · 1 investors · BiotechnologyRule 506(b)
▶$15MraisedDec 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adam D. CutlerExecutive Officer
- David R. HoffmannDirector
- Harold SelickDirector
- Kevin M. LalandeDirector
- David HirschDirector
- Eric E. PomaExecutive Officer, Director
- Roger WaltzmanExecutive Officer
- Jason S. KimExecutive Officer
- Jonathan LanfearDirector
- Scott MorensteinDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedAug 2017 · 1 investors · BiotechnologyRule 506(b)
▶$20MraisedAug 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jason S. KimExecutive Officer
- Eric E. PomaExecutive Officer, Director
- David R. HoffmannDirector
- Michael BroxsonDirector
- David HirschDirector
- David ValacerExecutive Officer
- Scott MorensteinDirector
- Kevin M. LalandeDirector
- Harold SelickDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40MraisedAug 2017 · 16 investors · BiotechnologyRule 506(b)
▶$40MraisedAug 2017 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott MorensteinDirector
- David ValacerExecutive Officer
- Kevin M. LalandeDirector
- David R. HoffmannDirector
- Eric E. PomaExecutive Officer, Director
- Harold SelickDirector
- David HirschDirector
- Jason S. KimExecutive Officer
- Michael BroxsonDirector
- Offering amount
- $40M
- Amount sold
- $40M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Molecular Templates?
- Molecular Templates was founded by Eric E. Poma.
- Who are Molecular Templates's investors?
- Molecular Templates's investors include Sante Health Ventures.
- How much funding has Molecular Templates raised?
- Molecular Templates has disclosed $95M raised across 4 rounds.
- Where is Molecular Templates headquartered?
- Molecular Templates is headquartered in Austin, US.